- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Diffuse pulmonary infiltrates as a roentgenographic manifestation of primary pulmonary plasmacytoma
Search this article
Description
5926) is the only yeast that has been tested in doubleblind studies (1). The manufacturer claims that S boulardii is not identical to S cerevisiae (2). However, some authors consider S cerevisiae to be synonymous with S boulardii, and have successfully treated patients with baker’s yeast for C difficile diarrhea (5). Treatment with S boulardii has previously been shown to cause invasive fungal disease in 7 patients (6 –10). All of these cases occurred in debilitated or immunosuppressed patients who had central venous lines. All patients, like ours, recovered with systemic antimycotic treatment.
Journal
-
- The American Journal of Medicine
-
The American Journal of Medicine 105 72-74, 1998-07-01
Elsevier BV